Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Extranodal NK-T-Cell 2 Biliary Tract Neoplasms 2 Thoracic Neoplasms 1 Squamous Non-small-cell Lung Cancer 1 Oligospermia 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Lymphohistiocytosis, Hemophagocytic 1 Lung Neoplasms 1 Lung Diseases 1 Fibrosis 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Adenocarcinoma Pancreas 1 Adenocarcinoma 1

Interventions

Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adenocarcinoma Pancreas × Gemcitabine × Clear all

NCT02812992 2021-08-10

GrantPax

AIO-Studien-gGmbH

Phase 4 Completed

Gastrointestinal

Adenocarcinoma Pancreas

Data powered by HemOnc (CC BY 4.0) Colophon ⚡